Secondly, the comprehensive analysis of a broad range of biomarkers, including D-dimer and IL-1β, allows for a detailed evaluation of the mechanisms behind ART-related side effects, particularly in patients with comorbid conditions like type II diabetes. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.